How high is the incidence of gallbladder cancer?

What is the incidence rate of gallbladder cancer? Experts say that gallbladder cancer is the most common malignant tumor in people's lives, and the mortality rate is also very high in our country. The incidence rate of gallbladder cancer patients is also showing an upward trend with the changes in people's living habits and dietary structure. Let us take a detailed look at the issue of the incidence rate of gallbladder cancer.

Among malignant tumors of the gallbladder, gallbladder cancer ranks first, and others include sarcoma, carcinoid, primary malignant melanoma, giant cell adenocarcinoma, etc. Primary gallbladder cancer is relatively rare in clinical practice and has not attracted people's attention for a long time. According to domestic textbooks, it only accounts for about 1% of all cancers.

The incidence of gallbladder cancer ranks fifth among digestive tract tumors and first among biliary tract tumors, but there is currently a lack of large-scale epidemiological survey data on the incidence of gallbladder cancer. In 1989, Cui Yan et al. collected data on primary gallbladder cancer reported in China since 1941, which accounted for 2% to 5% of biliary tract surgeries during the same period. Stauchco reported that the incidence of gallbladder cancer was 25,100. However, the incidence of gallbladder cancer varies greatly in different regions and different races. For example, the incidence of gallbladder cancer in Indians is 6 to 8 times the national average, while European and American countries reported that gallbladder cancer accounted for about 4.1% to 5.6% of biliary tract surgeries during the same period.

After reading the above detailed introduction, people should have some understanding of the incidence of gallbladder cancer. Through the above introduction, we will also find that the incidence of gallbladder cancer in our country is still very high, and there is a trend of gradual increase. We should pay attention to the prevention of gallbladder cancer.